Why is "Hoffmann-La Roche" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-31 02:10:09
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
Related Topics
Trending Topic Today
Search Interest Perspective
-
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply - Yahoo Finance Singapore
-
Hoffmann-La Roche lands PI against Menarini Diagnostics from UPC - juve-patent.com
-
Biotech Giant Roche To Triple Investment Footprint on Harvard’s Enterprise Research Campus - The Harvard Crimson
-
Welcome to Basel: the birthplace of Roche - Roche
-
F. Hoffmann-La Roche Ltd - Via Ritzau
-
China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche - Reuters
-
Delhi High Court’s Ruling in F. Hoffmann-La Roche Ag & Anr. V. Natco Pharma - Cyril Amarchand Mangaldas
-
Accord Challenges Roche's Patent Over Herceptin Reformulation - Law360
-
Early data suggest Roche’s NXT007 may have the potential to - GlobeNewswire
-
Roche plans $700m manufacturing plant in the US - Pharmaceutical Technology
-
News | Reimagining of Ex-Hoffmann-La Roche Campus Enters Next Stage With Anchor Office Tenant Eisai - CoStar
-
Roche Canada announces Polivy® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma is now Publicly Reimbursed in Québec - Newswire Canada
-
Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine) - Yahoo Finance UK
-
Holistic care in Brazil - Roche
-
Roche announces $50bn US investment in pharma and diagnostics - Pharmaceutical Technology
-
F. Hoffmann-La Roche Ltd - Via Ritzau
-
Avastin (bevacizumab) - Roche
-
Fighting inflammation in the eye - Roche
-
Roche and BARDA: Partnering for better brain health - Roche
-
Diagnostics in oncology - Roche
-
HOFFMANN-LA ROCHE MAY BUILD $500 MILLION FACILITY IN SC - Journal of Commerce
-
No one can deny the existence of climate change - Roche
-
Life After Hoffmann-La Roche: ON3 In Nutley, Clifton Gets More Awards - Patch
-
Learn why Roche chose Canada for it's Global Informatics Hub - Invest Ontario
-
Japan-based pharmaceutical company to bring 1,200 employees to former Hoffmann-La Roche site - Bergen Record
-
AI and machine learning: Revolutionising drug discovery and transforming patient care - Roche
-
Ex-Hoffmann-La Roche Employees Return To ON3 In Nutley - Patch
-
Hoffmann-La Roche Whistleblower Drops Tamiflu Fraud Suit (2) - Bloomberg Law News
-
News | Prism Capital Relocates Headquarters to Former Hoffmann-La Roche Site - CoStar
-
F Hoffmann La Roche Ltd - Reuters
-
Q&A with Hoffmann-La Roche’s Rana Kassab - Benefits Canada.com
-
The Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too - Fortune
-
Drone video: Clifton/Nutley former Hoffmann-La Roche site is now "ON3" - Lions Wire
-
More Growth At Ex-Hoffmann-La Roche Site In Nutley, Clifton - Patch
-
Five-star luxury hotel, conference center eyes former Hoffmann-La Roche site - Bergen Record
-
MOMA Therapeutics and Roche sign cancer drug discovery deal - Pharmaceutical Technology
-
Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab - Yahoo Finance
-
GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex - Yahoo Finance
-
Transformation of Former Pharmaceutical Complex in Nutley and Clifton Continues - Jersey Digs
-
SBTi validates Roche’s net-zero targets - Roche
-
Cancer drug Herceptin: setbacks for Hoffmann-La Roche - juve-patent.com
-
Former Hoffmann-La Roche Site In Nutley Sold: N.J. Developer Closes Deal - Patch
-
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche - Yahoo Finance
-
Hackensack University Health Network and Seton Hall University Announce Joint Venture to Form School of Medicine - New Jersey Business Magazine
-
Neurology Market Research Overview 2025, Profiles of Major Players - F. Hoffmann-La Roche, Novartis, UCB, and Otsuka - ResearchAndMarkets.com - Business Wire
-
The $1.3 billion share sale that has rocked one of the world’s richest families - SMH.com.au
-
Heaven's eyes: Luc Hoffmann, unsung hero of nature conservation - theecologist.org
-
Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus - The Harvard Crimson
-
Nutley Meeting On Former Hoffmann-La Roche Site: What’s Next? - Patch
-
Luc Hoffmann obituary - The Guardian
-
ON3 site along Route 3 in Clifton gets OK to build new restaurant - Bergen Record
-
F. Hoffmann-La Roche Ltd - Via Ritzau
-
2005: Death of Chemist Who Discovered Valium - Jewish World - Haaretz
-
Roche acquires Irish biotech firm Inflazome for $449m - Pharmaceutical Technology
-
Power Plant Upgrades Planned At ON3 Complex In Nutley, Clifton - Patch
-
Drone video: Clifton/Nutley former Hoffmann-La Roche site is now "ON3" - List Wire
-
Bridging academia and industry - Roche
-
Roche's Annual Report 2022 - Roche
-
ON3 campus: Developer replaces 14 stories of marble for clear views of NYC - Bergen Record
-
The generation game: the women behind the Emanuel Hoffmann Foundation - The Art Newspaper
-
Roche Diagnostics to create Software Development Hub in Laval - Montréal International
-
Pioneering in antibiotics - Roche
-
Roche’s Annual Report 2024 - Roche
-
'Major Data Center' May Be Coming To ON3 Site In Nutley, Other Updates Announced - Patch
-
Roche’s Annual Report 2023 - Roche
-
A Short History of Accutane - MedShadow Foundation
-
Supreme Court Dismisses Roche's Plea To Restrain Natco From Making Generic Drug For SMA; Asks Delhi HC To ... - Live Law
-
Saudi pharma sector takes leap forward with Hoffmann La Roche localization deal - Arab News
-
Hoffmann-Oeri Family - Tharawat Magazine
-
Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024 - PR Newswire
-
ON3 site in Clifton proposes next project ahead of residential phase. See what's coming - Bergen Record
-
Roche Bulk Active Ingredient Manufacturing Facility, Florence, SC - Pharmaceutical Technology
-
Switzerland’s Biggest Family Fortune Has Prospered for 124 Years - bloomberg.com
-
Roche descendant André Hoffmann on pharma, feuds and family business - SWI swissinfo.ch
-
From the archives: In hunt for killer, police will revisit a 1968 mystery (2005) - NJ.com
-
Environmental cleanup continues at Roche campus as new medical school planned for site - NJ.com
-
Roche will close Nutley plant, shed nearly 1,000 jobs - NJ.com
-
Ex-Roche Site Booming In Nutley: Med School, Ralph Lauren - Patch
-
New Labs Will Add To Rebirth Of Ex-Roche Site In Nutley, Clifton - Patch
-
Annual Report 2020 - Roche
-
Saddened Town Recalls History With Drug Giant (Published 2012) - The New York Times
-
We must act and do what is right: F. Hoffmann-La Roche’s CPO - People Matters - HR News
-
Seven Swiss billionaires unmasked as Roche surges - PressReader
-
Intas settles patent litigation with Hoffmann-La Roche for capecitabine tablet - The Economic Times
-
Roche Canada expands global informatics hub in Ontario - Invest Ontario
-
Roche Canada Announces Columvi® (glofitamab for injection) is Publicly Reimbursed in 7 Provinces, Including Quebec, Ontario, Manitoba, Saskatchewan, Nova Scotia, and Newfoundland - Newswire Canada
-
Swiss company Hoffmann-La Roche agreed to reduce the price of medicines for cancer patients in Armenia - АрмИнфо
-
COMPANY NEWS; Executive Changes at La Roche (Published 1992) - The New York Times
-
Toward a Sobriety Pill - The Washington Post
-
Roche Vitamins and Minerals Premix Plant, Republic of South Africa - Pharmaceutical Technology
-
SC agrees to hear Cipla's plea against La Roche - ET HealthWorld
-
Dr. Virginius Mattia, 48, Dies; Hoffmann‐La Roche President (Published 1971) - The New York Times
-
Remembering whistleblower Stanley Adams - 'a proud man' who stood up for his beliefs - Dorset Echo
-
Roche shareholders' pool: Inclusion of the fifth generation completed - Presseportal.ch
-
A Vitamin C Factory Opens in Belvidere (Published 1972) - The New York Times
-
Roche vs Zydus: Supreme Court asks Delhi High Court to expeditiously decide cancer drug case - Bar and Bench
-
F Hoffman-La Roche Ltd v Cipla Ltd Expert Analysis - Bar and Bench
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.